Press release
Neuropathic Pain Market Growth Factors and Manufacturers
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would be the trend followed by the physical therapy market going forward.
Get Free Sample Copy Of Neuropathic Pain Market Report@ https://www.persistencemarketresearch.com/samples/4149
Reaching the revenues of over US$ 6 Bn at the end of 2019, the global neuropathic pain management market is projected for a healthy CAGR during the forecast period (2019 - 2029). Increasing prevalence of neuropathic pain disorders and growing awareness about pain medication are boosting the demand for pain management drugs.
Pipeline strategies by manufacturers are focused on introducing advanced drugs with minimum side effects to increase market share. For instance, Pfizer sponsored drug Pregabalin, effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma that is in phase 3 clinical trials. Increasing research and development activities to develop medications for indications such as post-herpetic neuralgia are creating significant opportunities for manufactures to flourish in the market.
Company Profiles
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Sanofi S.A
• GlaxoSmithKline plc
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd
• Baxter International Inc
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Neuropathic Pain Market? https://www.persistencemarketresearch.com/methodology/4149
Key Takeaways - Neuropathic Pain Management Market Study
• Attributed to less side effects, tricyclic antidepressant drugs are expected to be popular as compared to opioids and steroids during the forecast period.
• North America is expected to be significant revenue generator owing to emergence of several regional market players and well-developed healthcare infrastructure.
• Retail pharmacies are expected to be dominant distribution channels in the neuropathic pain management market.
Increasing prevalence of diabetic neuropathy and availability of approved neuropathy pain medications have significantly added to the opportunities for market growth, thereby fostering the rate of adoption of neuropathic pain management drugs.
Increasing R&D Spending by Pharmaceuticals Companies Shaping Future
One of the key factors observed to impact the neuropathic pain management market growth is the development of new drugs for treatment of neuropathic and chronic pains. Companies are focusing on clinical trials to develop drugs for efficient treatment of neuropathic pain. For instance, Eli Lilly and Company developed Duloxetine (LY248686) for Diabetic Peripheral Neuropathic Pain (DPNP) that is under phase 4 clinical trial.
Go To "Purchase Now" To Have Our Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/checkout/4149
At the same time, companies are focused on expanding therapeutic applications of drugs such as opioids and steroids for neuropathic pain management without causing any serious side effects to patients. Currently, more than 100 clinical trials are been carried out for pain management. Among those clinical trials, nearly half of the clinical trials are for various indications of neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia.
What Does the Report Cover?
The neuropathic pain management market, a new study from Persistence Market Research, provides unparalleled insights on evolution of the neuropathic pain management market during 2014 - 2018 and presents demand projections during 2019 - 2029 on the basis of drug class (tricyclic anti-depressants, anticonvulsants, SNRI's, capsaicin cream, local anesthesia, opioids, steroids, and others), indication (diabetic neuropathy, trigeminal neuralgia, post-herpetic neuralgia, chemotherapy-induced peripheral neuropathy and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies) across prominent regions (North America, Latin America, Europe, Asia Pacific and MEA).
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market Growth Factors and Manufacturers here
News-ID: 2736207 • Views: …
More Releases from Persistence Market Research
Cloud-Based Cold Chain Management Market Powering the Future of Temperature-Cont …
The cloud-based cold chain management market is emerging as a critical backbone for modern temperature-sensitive supply chains across food, pharmaceuticals, and life sciences. As per the provided data, the global market is expected to be valued at US$ 8.1 Bn by 2024 and is projected to reach US$ 24.5 Bn by 2031, expanding at a robust CAGR of 21.6%. This rapid growth reflects the rising dependence on digital platforms to…
Penetration Testing as a Service Market: Defending Digital Assets Against Next-G …
The penetration testing as a service market has emerged as a critical pillar of modern cybersecurity strategies, driven by the exponential rise in digital transformation initiatives across industries. As enterprises increasingly migrate workloads to cloud environments, deploy complex IT infrastructures, and rely on interconnected systems, the need to identify and remediate vulnerabilities before malicious actors exploit them has become paramount. Penetration testing as a service (PTaaS) offers organizations continuous, scalable,…
Smart Ticketing Market to Reach USD 35.9 Billion by 2032, Registering a 14.3% CA …
The global smart ticketing market is undergoing a fundamental transformation as cities, transit authorities, and entertainment venues accelerate their shift toward digital-first access systems. Valued at US$ 14.1 billion in 2025, the market is projected to reach US$ 35.9 billion by 2032, expanding at a strong CAGR of 14.3% during the forecast period. This growth reflects rising demand for frictionless travel, paperless operations, and enhanced customer experiences across transportation and…
Smart Animal Trap Market Valued at US$ 451.3 Mn in 2026, Poised for Strong Growt …
Introduction
The global smart animal trap market is gaining strong momentum as technology-driven wildlife management, pest control, and humane animal capture solutions become increasingly important across residential, commercial, agricultural, and conservation applications. Smart animal traps integrate advanced technologies such as sensors, cameras, wireless connectivity, and real-time monitoring systems to improve trapping efficiency while minimizing harm to animals. These systems are designed to provide alerts, remote access, and data-driven insights, enabling faster…
More Releases for Neuropathic
Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Inte …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%;…
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also…
